Novonesis AS — Major Shareholding Notification 2016

Apr 1, 2016

In accordance with section 29 of the Danish Securities Trading Act, Novozymes
hereby announces that it has been informed that Baillie Gifford & Co, together
with its wholly owned subsidiary Baillie Gifford Overseas Limited, now holds
5.04% of the B shares in Novozymes, previously reported at 4.99% in company
announcement no. 14, March 2016.

Baillie Gifford & Co, together with its wholly owned subsidiary Baillie Gifford
Overseas Limited, now holds B shares in Novozymes A/S to a total of 15,639,344
shares of a nominal value of DKK 31,278,688, equivalent to 5.04% of Novozymes
A/S’ share capital and 1.97% of the voting rights.